Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 747.65
-7.05 (-0.93%)
Jul 13, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 425.04 billion as of July 13, 2026.
Market Cap
425.04B
Enterprise Value
416.20B
Revenue
21.29B
Ranking
n/a
PE Ratio
72.36
Stock Price
747.65
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 425.04B, an increase of 3.63%. That is a compound annual growth rate of 3.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 425.04B | 16.17% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 677.29B |
| OneSource Specialty Pharma | 186.52B |
| Concord Biotech | 136.49B |
| Blue Jet Healthcare | 108.25B |
| Supriya Lifescience | 68.78B |
| Zota Health Care | 49.28B |
| Panacea Biotec | 33.48B |
| Dishman Carbogen Amcis | 30.71B |